Clinical Trial Update: Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of solamargine in patients with actinic keratosis has completed, evaluating how the drug behaves in humans.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Solamargine (solamargine)

Snippet

Sponsor: G&E Herbal Biotechnology Co., LTD | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED